Biotest Pharmaceuticals Corporation Announces the Relocation of its Plasma Collection Facility in San Antonio, Texas

BOCA RATON, Fla., April 2, 2015 /PRNewswire/ -- Biotest Pharmaceuticals Corporation (BPC), a leading developer of immunology biotherapeutic products, is pleased to announce the relocation of its plasma collection center to 618 NW Loop 410 Suite 101 San Antonio, Texas. The 18,000 square foot state-of-the-art facility officially opened its doors for business on Sunday, March 29^th 2015.

"This facility relocation represents our continued commitment to better serve our donors that help the thousands of patients world-wide that rely on plasma based therapies" said Jordan Siegel, BPC's Chief Executive Officer. 

The plasma donated at Biotest Plasma Centers is used to manufacture critical care therapies that treat life threatening disorders in a variety of therapeutic areas, such as BPC's BIVIGAM^® [Immune Globulin Intravenous (Human), 10% Liquid] and Nabi-HB^® [Hepatitis B Immune Globulin (Human)]. 

The Company expects this newly relocated facility to expand its current workforce to over 50 employees and currently has employment opportunities available for medical personnel and phlebotomists.

In addition to supporting the local economy through employment opportunities, the plasma center is actively recruiting local residents to donate plasma.  Plasma donors not only contribute the source material for these plasma derived therapies that save the lives of thousands of patients but also are compensated for their donations.

About Biotest Pharmaceuticals Corporation

Biotest Pharmaceuticals Corporation, a wholly owned subsidiary of Biotest AG, a German global provider of plasma therapies, researches, develops and manufactures biotherapeutic products with a specialization in immunology and hematology. BPC is a leader in the collection of source plasma and is currently involved in the development of plasma protein products in the field of Primary Immune Deficiency (PID) and various hyperimmune (IG) products. The Company owns and manages eighteen plasmapheresis centers across the United States and a state-of-the-art manufacturing facility in Boca Raton, Florida. The Company employs more than 900 people in the U.S. To learn more about Biotest Pharmaceuticals and our Plasma Centers and the difference we make in the lives of patients and the healthcare community, please visit us at www.biotestpharma.com and www.biotestplasma.com.

SOURCE Biotest Pharmaceuticals Corporation

Related Links

http://www.biotestpharma.com